{"text": "TITLE:\n      Protein Supplementation and Weight Loss\nSUMMARY:\n      This randomized control trial of diet with protein supplementation is being conducted to\n      test the hypothesis that in overweight/obese subjects high protein diet may lead to weight\n      loss and improvement in cardio-metabolic profile.\nELIGIBILITY CRITERIA:\n      Inclusion Criteria:\n          1. Subjects aged between 21 -65 years\n          2. Subjects with BMI > 23 Kg/m2\n        Exclusion Criteria:\n          -  Inclusion Criteria:\n               1. Subjects aged between 21 -65 years\n               2. Subjects with BMI > 23 Kg/m2\n        Exclusion Criteria:\n          1. Diabetes (type 1 and type 2)\n          2. Known or documented coronary heart disease (CHD) (including ECG consistent with prior\n             myocardial infraction), cerebrovascular accident (including transient ischemic\n             attack), peripheral vascular disease (including symptoms of claudication)\n          3. Angina or other chest pain that may indicate CHD by history\n          4. Clinically significant neoplastic, cardiovascular, hepatic, renal, metabolic,\n             endocrine (untreated or unstable), or psychiatric (untreated or unstable) by history\n          5. Medications: Lipid lowering therapy, daily NSAID or greater than 325 mg ASA (PRN use\n             ok), clopidogrel (or equivalent), Coumadin, other investigational drugs within 30\n             days of study entry\n          6. Pregnancy or planning pregnancy during the study period by history\n          7. Uncontrolled hypertension\n          8. Uncontrolled hypothyroidism\n          9. Sensitivity or allergy to product by history\n         10. Subjects who had undergone bypass procedure\n         11. Any debilitating disease such as tuberculosis, HIV by history .\n         12. Unwillingness to give written informed consent for participation in the study\n", "cuis": "C0242297 C0242296 C1262477 C0202202 C0555903 C0033621 C0919677 C1168438 C1949480 C0038164 C0919678 C1552616 C1706244 C0770246 C0556080 C0012159 C1549512 C0282440 C0425403 C0497406 C0424653 C1305866 C2053618 C0028754 C0392366 C0456984 C1442948 C3844714 C2707259 C0243161 C0013893 C0243161 C0243161 C0243161 C0243161 C0011847 C0011849 C0011860 C0010054 C0010068 C1956346 C1277690 C0034072 C1301725 C1609436 C1301746 C1547673 C1563337 C0038454 C3536593 C0687129 C1550450 C0022116 C0085096 C0553983 C0162819 C0199686 C0011871 C3698278 C0311395 C1456822 C2024884 C0239064 C0522034 C1457887 C1304680 C0008031 C2926613 C0262926 C2004062 C0002962 C2926611 C3887460 C0007220 C0436125 C0497234 C0205054 C0022646 C3272565 C2707259 C0332155 C0443343 C0262926 C2004062 C1548428 C3526598 C0013227 C0802604 C2598133 C2094204 C3840903 C3843493 C3843494 C0087111 C0033972 C0003211 C0700848 C1820370 C0523744 C0013230 C0070166 C0699129 C1564394 C0947630 C0032992 C0032961 C3484365 C0425965 C3843687 C3843688 C3843689 C3843690 C3843691 C3843692 C0262926 C2004062 C0025344 C0947630 C1868885 C0020676 C0455486 C0857250 C0020517 C0312418 C0427965 C0489531 C1527304 C0719113 C0719656 C3247823 C0262926 C2004062 C0184661 C0025664 C0944777 C0945766 C1948041 C3538935 C3539779 C0449999 C1144702 C0741847 C0041296 C0041312 C1396850 C0003448 C0030524 C0041322 C0152874 C0206526 C0275904 C0857427 C0012634 C0018609 C0262926 C2004062 C0947630 C0009797 ", "concepts": "Supplementation, Food Supplementation, Weight Loss, Protein, Protein, Protein C, Protein C, Protein C, Protein C, Protein A, Protein S summary, summary protein supplementation, Animal protein supplementation, diet, diet, randomized controlled trial high protein diet, overweight, weight, weight, weight, obese, test, test, lead No improvement, Metabolic criteria, Eligibility Criteria Criteria Criteria Criteria Diabetes, Diabetes, diabetes coronary heart disease, CHD (coronary heart disease), coronary heart disease, coronary heart disease risk, Pulmonary heart disease, Documented, Documented, document, document, document cerebrovascular accident, Chronic cerebrovascular accident, transient, Transient, ischemia PVD - Peripheral vascular disease, Other peripheral vascular diseases, peripheral vascular disease of skin, Peripheral vascular disease study, Diabetic peripheral vascular disease, Secondary peripheral vascular disease, claudications, claudication, claudications, Jaw claudication, Arm claudication, symptoms, attack chest pain, Chest pain, history, history, Angina, Angina cardiovascular, cardiovascular drug, cardiovascular exam, Pain;cardiovascular, hepatic, renal, Clinical, Metabolic untreated, unstable, history, history, Psychiatric, Psychiatric medications, Medications, Medications, medications:, Medication 2, Medication 3, Medication 1, therapy, Cotherapy, nsaid, Ansaid, flowering, Lipids investigational drugs, clopidogrel, Coumadin, Coumadine study planning pregnancy, pregnancy, Pregnancy, ? Pregnancy, Pregnancy 6, Pregnancy 5, Pregnancy 4, Pregnancy 3, Pregnancy 2, Pregnancy 1, history, history, period, study Uncontrolled hypertension hypothyroidism, H/O: hypothyroidism, Uncontrolled INR allergy, Sensitivity, Sensitivity, allergy, allergy, Callergy, dallergy, Dallergy, history, history Procedure, procedures, Procedure, Procedure, Procedure, Procedure, Procedure, Subprocedure, Ct procedure, bypass tuberculosis, GI tuberculosis, epituberculosis, antituberculosis, Paratuberculosis, eye tuberculosis, Ear tuberculosis, mdr tuberculosis, CNS tuberculosis, Old tuberculosis, disease, h disease, history, history study, informed consent form "}
